Classification ![]() |
|
| Compound class | Peptide or derivative |
| Approved drug? | Yes (source: EMA (2008), FDA (2011)) |
International Nonproprietary Names ![]() |
|
| INN number | INN |
| 6922 | icatibant |
Synonyms ![]() |
| D-Arg-[Hyp3,Thi5,D-Tic7,Oic8]BK |
| Firazyr® |
| HOE 140 |
| HOE140 |
Database Links ![]() |
|
| BindingDB Ligand | 50142947 |
| CAS Registry No. | 130308-48-4 (source: Scifinder) |
| ChEMBL Ligand | CHEMBL2028850 |
| DrugBank Ligand | DB06196 |
| PharmGKB Drug | PA164749185 |
| PubChem CID | 71364 |
| Search PubMed clinical trials | icatibant |
| Search PubMed titles | icatibant |
| Search PubMed titles/abstracts | icatibant |
| Wikipedia | Icatibant |
| Comments |
| Synthetic analogue of bradykinin. There is some ambiguity in the literature and on online resources as to the exact chemical structure and stereochemistry of icatibant. Therefore, we have chosen not to include a chemical structure here. Users should note that there may not be agreement in the structures represented in the external links provided above. |